Chemoinformaics analysis of GANOLUCIDENIC-ACID-B
| Molecular Weight | 502.692 | nRot | 6 |
| Heavy Atom Molecular Weight | 456.324 | nRig | 23 |
| Exact Molecular Weight | 502.329 | nRing | 4 |
| Solubility: LogS | -4.687 | nHRing | 0 |
| Solubility: LogP | 3.074 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 85.5845 |
| nHD | 3 | BPOL | 48.7515 |
| QED | 0.474 |
| Synth | 5.036 |
| Natural Product Likeliness | 3.088 |
| NR-PPAR-gamma | 0.97 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.477 |
| Pgp-sub | 0.018 |
| HIA | 0.172 |
| CACO-2 | -5.322 |
| MDCK | 0.0000206 |
| BBB | 0.981 |
| PPB | 0.867091 |
| VDSS | 0.426 |
| FU | 0.0864813 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.145 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.902 |
| CYP2c9-inh | 0.047 |
| CYP2c9-sub | 0.872 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.238 |
| CYP3a4-inh | 0.035 |
| CYP3a4-sub | 0.221 |
| CL | 16.295 |
| T12 | 0.263 |
| hERG | 0.006 |
| Ames | 0.013 |
| ROA | 0.126 |
| SkinSen | 0.024 |
| Carcinogencity | 0.028 |
| EI | 0.008 |
| Respiratory | 0.845 |
| NR-Aromatase | 0.756 |
| Antiviral | Yes |
| Prediction | 0.698715 |